Theravance Biopharma (TBPH) Q4 Earnings and Revenues Lag Estimates

Theravance Biopharma (TBPH) came out with quarterly earnings of $0.06 per share, missing the Zacks Consensus Estimate of $0.44 per share. This compares to a loss of $0.05 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -86.47%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of $0.03 per share when it actually produced earnings of $0.04, delivering a surprise of +233.33%.Over the last four ...